Comprehensive Library Of Resveratrol News

Read the whole post »

Available in a PDF version as well – download here

“May the force be with you.” – Star Wars

Strange as it may seem, largely because of difficulties in figuring out how to commercialize on what it promises, both alternative and conventional medicine fail to put into practice a compelling discovery that promotes health and longevity in an unmatched fashion.

It’s not a high-tech invention. It is not a patentable process. It is not a machine or a drug. Nor is it new. It has been recognized in the medical literature for decades now.

It is an adaptive internal response to mild biological threats that trigger incomparable defenses in the human body.

Despite considerable personal investigation into this topic, even the most avid health nut or PhD pursuer of longevity is likely to have missed the greatest mechanism to promote the human healthspan and lifespan ever discovered because it is not found in our external world but is rather a built-in adaptive response within the human body that has many triggers.

Read the whole post »

So why is resveratrol averting mortal heart attacks in the animal lab, in preliminary studies restoring vision to humans who are battling an otherwise hopeless eye disease, and is considered to be the most promising anti-cancer molecule on the planet — and therefore addresses the three most feared health problems of humanity — yet relatively few Americans have adopted res-pills into their daily health regimens?

These questions and more are answered by Bill Sardi in his most recent e-book THE CASE FOR RESVERATROL: Why Aren’t More Americans Taking Resveratrol Pills?

Read the whole post »

In his new free online e-book, How The World Got Lost On The Road To An Anti-Aging Pill, health investigator Bill Sardi says three things have side-tracked humanity from finding that long sought-after fountain of youth or anti-aging pill that was the pursuit of explorers like Ponce de Leon and modern researchers like Linus Pauling.

Since the prospect of an anti-aging pill was first announced in late 2003, when a Harvard scientist first reported a red-wine molecule caused yeast cells to live far longer in a lab dish, the adoption of such red-wine pills has been puzzlingly slow.

Six years after that announcement, red-wine resveratrol (rez-vair-ah-trawl) pills have been adopted by fewer than 1 million Americans, generating sales of around $30 million (2008 estimate).  “Compare that to over $1 billion of sales of Viagra pills in their first year of availability,” says Sardi.

Read the whole post »